Maze Therapeutics GAAP EPS of -$0.45 beats by $0.10, revenue of $20M beats by $11.5M
Maze Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $25.46
+4.6% in 1d after detection
Post-detection moves
1h
—
1d
+4.6%
3d
-0.9%
7d
-0.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS